Trump Media and Technology Group Corp vs IQVIA Holdings Inc. Common Stock — how do they compare? Trump Media and Technology Group Corp trades at $8.12 (market cap $2.28B), while IQVIA Holdings Inc. Common Stock trades at $260.67 (market cap $42.61B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 18.7× Trump Media and Technology Group Corp's market cap, and IQVIA Holdings Inc. Common Stock is trading nearer its 52-week high, Trump Media and Technology Group Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Trump Media and Technology Group Corp for 17 Days and IQVIA Holdings Inc. Common Stock for 1 Days on average.
| DJT | IQV | |
|---|---|---|
Market Cap | $2.28B | $42.61B |
Volume | 3,148,379 | 988,398 |
Sector | Media | Health |
52-Week High | $17.07 | $275.02 |
52-Week Low | $7.06 | $156.66 |
Typical Hold Time | 17 Days | 1 Days |
Enterprise Value | $2.35B | $56.77B |
Signals from Pluang's Aura AI — not financial advice
DJT trades at $8.125, down 1.16% with a bearish technical signal. The company shows minimal revenue of $3.68M against massive losses of -$712M, resulting in a negative net margin of -28,860%. Cash flow trends reveal heavy investing outflows, while a proposed merger with TAE Technologies aims to pivot toward fusion energy development. The stock faces significant fundamental challenges despite oversold RSI indicators.
Outlook remains highly speculative with substantial execution risks. The merger could provide long-term upside if fusion technology commercializes, but current financials and negative profitability signal extreme caution. Investors face dilution risk and cash burn with no near-term profit visibility.
No Aura AI signal available yet.
Trailing returns across standard periods
Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.
Read more on DJT →IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →